Skip to main content

Rensselaer Polytechnic Institute (RPI)

Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

May 20, 2019

Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

Interdisciplinary project seeks to improve outcomes for high-risk prostate cancer patients

TROY, N.Y. —Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more precise and personalized. This work will be a critical component of a new interdisciplinary research project funded by the National Institutes of Health (NIH) that seeks to improve radiation therapy for high-risk prostate cancer patients. 

“In order to do precision medicine, you need to see better,” said Pingkun Yan, assistant professor of biomedical engineering at Rensselaer. “If you cannot see, you can’t do anything.” 

Yan’s expertise in imaging will support researchers from University of Texas Southwestern, led by Jing Wang, associate professor of radiation oncology, who are currently conducting a clinical trial using an approach known as stereotactic body radiation therapy (SBRT), which delivers high doses of radiation directly to a tumor. 

Multiple clinical trials have shown that high doses of radiation to prostate tumors can result in improved cancer outcomes, Yan said, but delivery of that radiation must be localized and precise to protect other healthy tissue nearby. 

One of the challenges with SBRT is that the prostate can move and deform during delivery. To make sure the accurate dose is being given in the right location, a reliable and accurate tumor tracking method is needed. But traditional ultrasound technology isn’t sensitive enough to differentiate between the prostate tumor and healthy tissue. 

That’s where Yan comes in. He and his team will develop an imaging method to help researchers distinguish between the healthy tissue and the tumor, so they can more accurately administer the radiation doses. 

More specifically, Yan will integrate SBRT with a temporal enhanced ultrasound method (TeUS) that he previously developed through a collaboration with the University of British Columbia, Queens University, and NIH. TeUS combines a series of ultrasound images, over time, so that researchers and doctors can visually separate the tumor from the healthy organ.  

“The tumor and the healthy tissue move a little differently. By observing that area over time, we extract a difference,” he said. 

Deep-learning techniques employed by Yan’s team will make this technique possible.

“We could obtain these images in the past, but didn’t have a good tool to analyze those images. With deep learning, with artificial intelligence, we are now able to decode the information and make it usable,” Yan said. 

This research is a prime example of the work being done by Yan and other members of the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer. Yan is also part of a Cancer Research Group within the Center. 

The research facility is a physical embodiment of The New Polytechnic, a model for education and research that emphasizes collaboration across disciplines in order to solve life science challenges.  

“Examples such as Professor Yan’s work show how Rensselaer’s depth and expertise as a technological university is changing health care by bringing new solutions to hard problems such as prostate cancer,” said Deepak Vashishth, director of CBIS. 

Yan also recently received a Bench-to-Bedside award grant, also from NIH, to focus on improving cancer detection through ultrasound imaging. 

He hopes the results of these collaborative, interdisciplinary projects will improve treatment for all patients.

Contact

Reeve Hamilton
Director of Media Relations and Communications

(518) 833-4277
hamilr5@rpi.edu

For general inquiries: newsmedia@rpi.edu

About Rensselaer Polytechnic Institute

Founded in 1824, Rensselaer Polytechnic Institute is America’s first technological research university. Rensselaer encompasses five schools, 32 research centers, more than 145 academic programs, and a dynamic community made up of more than 7,900 students and more than 100,000 living alumni. Rensselaer faculty and alumni include more than 145 National Academy members, six members of the National Inventors Hall of Fame, six National Medal of Technology winners, five National Medal of Science winners, and a Nobel Prize winner in Physics. With nearly 200 years of experience advancing scientific and technological knowledge, Rensselaer remains focused on addressing global challenges with a spirit of ingenuity and collaboration.